Stocks股票 / Health Care / PTCT
PTC Therapeutics, Inc. · Health Care
PTCT US listed · USD美股 · 美元
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.PTC Therapeutics, Inc. 是一家美国制药公司，专注于开发口服小分子药物和基因疗法，通过靶向孤儿病中的转录后控制（PTC）机制来调节基因表达。
Mid cap中盘 · $6B
Rate-sensitive利率敏感
Health Care
S&P 600标普600小盘Russell 2000罗素2000
$78.01
-$0.58 · -0.74%
52w low52周低 $42.01high高 $91.10
Constructive — building a base建设性 — 正在筑底
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
45
Neutral zone中性区域
vs 50-day average相对50日均线
+2.0% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+7.4% above上方
Long trend up长期向上
Volatility波动率
48th percentile第48百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0617days to go天后公布
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | PTCT | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 9.31x | 28.59 | |
| P/S市销率 | 3.67x | 2.97 | |
| Earnings yield盈利收益率 | 10.75% | 2.72 | |
| FCF yield自由现金流收益率 | 11.05% | 4.00 | |
| EV/EBITDA企业价值/EBITDA | 6.56x | 18.18 | |
| P/FCF市值/自由现金流 | 9.05x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 35.4%
Earnings per share每股收益
Free cash flow自由现金流
Operating margin营业利润率
50.1%
Net margin净利率
39.5%
FCF margin自由现金流利润率
41.1%
Balance-sheet quality财务体质 6/8
Bankruptcy risk: grey zone破产风险：灰色区
Return on equity股本回报率 -333%
Watch关注
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.46
Current ratio流动比率2.35
Capital allocation资本配置
Stock-based comp股权薪酬$74.5M
Share count change (1y)股数变化（1年）+4.9%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +46.9%空头仓位变动 +46.9%
Technical技术面
PTCT daily MACD crossed downPTCT 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$36.6M net (0 buyers, 11 sellers)-$36.6M 净值（0 买家，11 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 5.2% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-16 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-06-16 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部
Jul 13, 2026
PTCT daily MACD crossed downPTCT 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $81.33.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$81.33。
Jul 9, 2026
PTCT made a new 52-week highPTCT 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $89.55.价格创出52周新高 — 全市场关注的动量/趋势极值。$89.55。
Jul 7, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
PTCT made a new 52-week highPTCT 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $89.20.价格创出52周新高 — 全市场关注的动量/趋势极值。$89.20。
Jul 7, 2026
PTCT RSI reached overboughtPTCT RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $89.20.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$89.20。
Jul 6, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 2, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 1, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 30, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Showing the last 15 of显示最近15条，共 239 signals条信号
Company profile公司档案
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.PTC Therapeutics, Inc. 是一家美国制药公司，专注于开发口服小分子药物和基因疗法，通过靶向孤儿病中的转录后控制（PTC）机制来调节基因表达。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Inventory build
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 9.3× | 28.6× | 97% |
| Price / Sales市销率 | 3.7× | 3.0× | 41% |
| EV / EBITDAEV/EBITDA | 6.6× | 18.2× | 96% |
| Earnings yield盈利收益率 | 10.8% | 2.7% | 98% |
| Free-cash-flow yield自由现金流收益率 | 11.2% | 5.5% | 88% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
79/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
62/100 — middle of the pack居中
vs market, 6 months相对大盘（6个月）
46/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
84/100 — stronger than most强于多数
Rank in sector行业内排名
#41 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -4.1% | -0.9% |
| 1 Month近1月 | -1.2% | -0.6% |
| 3 Months近3月 | +10.4% | +5.4% |
| 6 Months近6月 | +3.2% | +8.6% |
| Year to date年初至今 | +1.7% | +8.9% |
| 1 Year近1年 | +63.8% | +19.2% |
| 3 Years近3年 | +97.4% | +69.9% |
Trading information交易信息
Beta vs market贝塔
0.74
Volatility rank波动率分位
48th pctile
Short interest空头占比
21.2% of float
Market cap市值
$6B
EPS (trailing)每股收益
$8.38
Off 52-week high距52周高点
-12.9%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $381M | $539M | $699M | $938M | $807M | $1.7B |
| EPS每股收益 | $-6.64 | $-7.43 | $-7.79 | $-8.37 | $-4.73 | $7.78 |
| Free cash flow自由现金流 | $-212M | $-280M | $-389M | $-187M | $-114M | $702M |
| Gross margin毛利率 | — | — | — | — | — | — |
| Net margin净利率 | -115.1% | -97.3% | -80.0% | -66.8% | -45.0% | 39.4% |
| FCF margin自由现金流利润率 | -55.7% | -51.9% | -55.6% | -19.9% | -14.2% | 40.6% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$1.7B
Net income净利润
$683M
Operating cash flow经营现金流
$711M
Total assets总资产
$2.9B
Shareholder equity股东权益
$-205M
Long-term debt长期负债
$286M
Shares outstanding总股本
0.08B
Returns & growth回报与增长
Return on equity股本回报率
-332.7%
Return on assets资产回报率
23.6%
Debt / assets负债/资产
9.9%
Asset growth资产增速
+70.0%
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量：应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: inventory & receivables lean vs sales营运资本：存货与应收相对销售保持精简
- Capital discipline: share count +16.9% over 6 years (dilution)资本纪律：股本 6 年增加 16.9%（稀释）
- Balance sheet: Altman Z 1.92 — grey zone资产负债表：Altman Z 1.92——灰色区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
45
RSI (2-day)RSI（2日）
13
vs 20-day average相对20日均线
-5.7%
vs 50-day average相对50日均线
+2.0%
vs 200-day average相对200日均线
+7.4%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
56/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
1
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+27.0%
Net upgrades, 30 days净上调（30天）
+1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 5.2% | $528M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
0 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 0]}{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$36.6M
Insider buyers vs sellers内部人买家vs卖家
0 : 11
Short interest空头占流通盘
21.2%
Days to cover回补天数
5.4
Short interest change空头变化
+46.9%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
May · 100%
Weakest month最弱月份
Jan · 33%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -0.3% | 3 |
| Feb2月 | 67% | +8.7% | 3 |
| Mar3月 | 67% | +0.8% | 3 |
| Apr4月 | 33% | -0.2% | 3 |
| May5月 | 100% | +14.1% | 3 |
| Jun6月 | 50% | +0.8% | 4 |
| Jul7月 | 50% | +7.5% | 4 |
| Aug8月 | 33% | -1.7% | 3 |
| Sep9月 | 67% | +5.5% | 3 |
| Oct10月 | 67% | +9.6% | 3 |
| Nov11月 | 100% | +22.2% | 3 |
| Dec12月 | 67% | +5.0% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。